SM

Sabby Management Portfolio holdings

AUM $13M
This Quarter Return
-0.35%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$396M
AUM Growth
+$396M
Cap. Flow
-$33.8M
Cap. Flow %
-8.54%
Top 10 Hldgs %
35.42%
Holding
254
New
59
Increased
32
Reduced
45
Closed
40

Sector Composition

1 Healthcare 57.32%
2 Energy 8.8%
3 Technology 1.44%
4 Communication Services 1.02%
5 Industrials 0.84%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALKS icon
151
Alkermes
ALKS
$4.95B
0
ALNY icon
152
Alnylam Pharmaceuticals
ALNY
$58.6B
0
AMG icon
153
Affiliated Managers Group
AMG
$6.55B
0
AMRN
154
Amarin Corp
AMRN
$311M
0
ANIP icon
155
ANI Pharmaceuticals
ANIP
$2.06B
0
ARWR icon
156
Arrowhead Research
ARWR
$3.84B
-74,204
Closed -$502K
AXGN icon
157
Axogen
AXGN
$718M
-318,136
Closed -$1.11M
BCRX icon
158
BioCryst Pharmaceuticals
BCRX
$1.74B
0
BHC icon
159
Bausch Health
BHC
$2.72B
0
BIIB icon
160
Biogen
BIIB
$20.8B
0
BLRX
161
BioLineRX
BLRX
$15.5M
-744,401
Closed -$1.57M
BLUE
162
DELISTED
bluebird bio
BLUE
0
BMRN icon
163
BioMarin Pharmaceuticals
BMRN
$11.3B
0
BMY icon
164
Bristol-Myers Squibb
BMY
$96.7B
0
CASI icon
165
CASI Pharmaceuticals
CASI
$36.1M
$0 ﹤0.01%
+243,201
New
CERS icon
166
Cerus
CERS
$251M
-100,000
Closed -$417K
CRDF icon
167
Cardiff Oncology
CRDF
$130M
-15,000
Closed -$102K
CTSO icon
168
Cytosorbents Corp
CTSO
$61.5M
0
CYH icon
169
Community Health Systems
CYH
$392M
-27,569
Closed -$1.44M
CYTK icon
170
Cytokinetics
CYTK
$5.98B
0
DHR icon
171
Danaher
DHR
$143B
-62,453
Closed -$5.3M
EDAP
172
EDAP TMS
EDAP
$103M
0
ESPR icon
173
Esperion Therapeutics
ESPR
$490M
-5,000
Closed -$463K
EXAS icon
174
Exact Sciences
EXAS
$9.33B
0
EXEL icon
175
Exelixis
EXEL
$9.95B
0